Press release - May 28th, 2015

Cerbomed with further partnership: Vagus nerve stimulation without surgery now available in Denmark, Finland and Sweden.

ERLANGEN/AALBORG, Mai 28th,  2015 – More than 30 percent of all epilepsy patients still suffer from continued occurrence of seizures, despite appropriate treatment with anticonvulsive drugs. For these patients, only few treatment alternatives are available at the moment. One promising therapy option is transcutaneous Vagus Nerve Stimulation (t-VNS), now also available for patients in Denmark, Sweden and Finland. This has been made possible by cerbomed‘s new distributor Cephalon A/S.
The Denmark-based company is well recognized as a specialist in Neuro applications, and as a supplier of high-technology medical systems and devices.
“With the transcutaneous vagus nerve stimulator NEMOS we are able to expand our expertise in neurology. So we are delighted to be able to make this treatment option available in our markets,” said Klaus Johansen, CEO of Cephalon Denmark.
“Patients with difficult-to-treat epilepsies show a high level of suffering. With Cephalon we have a strong partner on our side, who will support the patients regarding t-VNS therapy in Denmark, Finland and Sweden,” said Dr. Andreas Hartlep, CEO of cerbomed GmbH.
About t-VNS with NEMOS
Transcutaneous Vagus Nerve Stimulation is addressed to patients suffering from various difficult-to-treat neurological and psychiatric diseases. The t-VNS therapy uses the fact that a branch of the vagus nerve is located directly under the skin in areas of the outer ear and therefore can be stimulated through the skin (transcutaneously) with electrical impulses.
With NEMOS cerbomed developed and patented a special stimulator and a dedicated ear electrode for treatment of epilepsies with t-VNS.  The stimulator, which is connected with the ear electrode, sends out the electrical impulses. With the transcutaneous vagus nerve stimulator NEMOS a targeted stimulation of the vagus nerve is possible without the need of a surgery.

About Cephalon A/S
Cephalon is well recognized as the specialist in Neuro applications and as a supplier of high-technology medical systems and devices. Our solutions are used in a wide range of applications in the field of neurology/neuropsychological, psychologically, ophthalmology and sleep diseases. Customers are hospitals, private doctors and research labs in Denmark, Sweden and Finland.
Cephalon’s focus has always been on long lasting customer relations, quality in service and support, and knowledgeable employees.
Cephalon are represented in Denmark, Sweden and Finland. Main office is located in Aalborg, Denmark. For additional information please visit

About cerbomed
Cerbomed GmbH is an innovative medical device company located in Erlangen, Germany, that focuses on neuromodulation. The company, founded in 2005, focuses on transcutaneous Vagus Nerve Stimulation (t-VNS), which may offer an attractive therapy option for patients with hard-to-treat neurological and psychiatric illnesses.
The transcutaneous Vagus Nerve Stimulation received the European clearance (CE mark) for the treatment of epilepsies, depression and pain. Two clinical studies regarding the effectiveness of
t-VNS in patients with drug-resistant epilepsy and chronic migraine have been finished in 2014.

pdf Download Article

Please note: NEMOS® is not cleared or approved for use in the U.S.